Latest Superannuation News

Select Harvests appoints Kristina Hermanson as Managing Director and CEO, aiming to leverage her 25 years of global agribusiness expertise to drive the company’s next growth phase.

Ventia Services Group has appointed Mark Ralston as its new Managing Director and Group CEO, succeeding Dean Banks in a planned leadership transition set for September 2026.

EQT Holdings is stepping away from its superannuation trustee arm to sharpen focus on core corporate and wealth services, triggering a $13 million impairment and legal expenses in FY26.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Lendlease appoints seasoned real asset executive Nick O’Neil as CEO, marking a leadership shift aligned with its strategic reset and portfolio simplification.

Helia Group appoints Mark Senkevics as CEO from December 2026 and Craig Ward as CFO from July 2026, outlining detailed remuneration and transition plans amid ongoing leadership changes.

Heavy Rare Earths Limited has appointed Jason Barnett as Managing Director and CEO, aiming to leverage his extensive mining experience as the company advances its critical minerals projects and prepares for a maiden drilling campaign.

Elanor Investors Group appoints David McNamara as CEO, signaling a leadership shift following a balance sheet recapitalisation and strategic reset. The Board also sees key transitions with Tony Fehon moving to a non-executive role and Su Kiat Lim stepping down.

Bison Resources has appointed Tim Mackellar as CEO, leveraging his senior mining and capital markets experience to drive exploration and development efforts.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

Raiz Invest announces a leadership change with Brendan Malone stepping down as CEO and Craig Keary taking over, signalling a new chapter for the fintech amid steady growth.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.